Combined but not individual administration of beta-adrenergic and serotonergic antagonists impairs water maze acquisition in the rat
- PMID: 17653108
- DOI: 10.1038/sj.npp.1301518
Combined but not individual administration of beta-adrenergic and serotonergic antagonists impairs water maze acquisition in the rat
Abstract
This study examined the effects of serotonergic depletion and beta-adrenergic antagonism on performance in both visible platform and hidden platform versions of the water maze task. Male Long-Evans rats received systemic injections of p-chlorophenylalanine (500 mg/kg x 2) to deplete serotonin, or propranolol (20 or 40 mg/kg) to antagonize beta-adrenergic receptors. Some rats received treatments in combination. To separate strategies learning from spatial learning, half of the rats underwent Morris' water maze strategies pretraining before drug administration and spatial training. Individual depletion of serotonin or antagonism of beta-adrenergic receptors caused few or no impairments in either naive or pretrained rats in either version of the task. In contrast, combined depletion of serotonin and antagonism of beta-adrenergic receptors impaired naive rats in the visible platform task and impaired both naive and strategies-pretrained rats in the hidden platform task, and also caused sensorimotor impairments. This is the first finding of a 'global' water maze task/sensorimotor impairment with combined administration of two agents that, at the high doses that were given individually, produced few or no impairments. The data imply that (1) serotonergic and beta-adrenergic systems may interact in a manner that is important for adaptive behavior; (2) impairments in these systems found in Alzheimer patients may be important for their cognitive and behavioral impairments; and (3) the approach used here can model aspects of the cognitive and behavioral impairments in Alzheimer disease.
Similar articles
-
Combined beta-adrenergic and cholinergic antagonism produces behavioral and cognitive impairments in the water maze: implications for Alzheimer disease and pharmacotherapy with beta-adrenergic antagonists.Neuropsychopharmacology. 2003 Jul;28(7):1247-56. doi: 10.1038/sj.npp.1300163. Epub 2003 Apr 9. Neuropsychopharmacology. 2003. PMID: 12700678
-
Water maze impairments after combined depletion of somatostatin and serotonin in the rat.Behav Brain Res. 2007 Jul 19;181(1):85-95. doi: 10.1016/j.bbr.2007.03.029. Epub 2007 Mar 31. Behav Brain Res. 2007. PMID: 17477978
-
Serotonin-dependent maintenance of spatial performance and electroencephalography activation after cholinergic blockade: effects of serotonergic receptor antagonists.Brain Res. 1999 Aug 7;837(1-2):242-53. doi: 10.1016/s0006-8993(99)01669-8. Brain Res. 1999. PMID: 10434009
-
Assessment of age-associated cognitive deficits in rats: a tricky business.Neurosci Biobehav Rev. 2002 Nov;26(7):753-9. doi: 10.1016/s0149-7634(02)00062-3. Neurosci Biobehav Rev. 2002. PMID: 12470686 Review.
-
IL1 beta impairs relational but not procedural rodent learning in a water maze task.Adv Exp Med Biol. 1996;402:207-17. doi: 10.1007/978-1-4613-0407-4_27. Adv Exp Med Biol. 1996. PMID: 8787662 Review. No abstract available.
Cited by
-
Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease.J Neurosci. 2008 Dec 17;28(51):13805-14. doi: 10.1523/JNEUROSCI.4218-08.2008. J Neurosci. 2008. PMID: 19091971 Free PMC article.
-
Alzheimer's therapeutics: translation of preclinical science to clinical drug development.Neuropsychopharmacology. 2012 Jan;37(1):261-77. doi: 10.1038/npp.2011.211. Epub 2011 Sep 21. Neuropsychopharmacology. 2012. PMID: 21937983 Free PMC article. Review.
-
Noradrenergic dysfunction in Alzheimer's disease.Front Neurosci. 2015 Jun 17;9:220. doi: 10.3389/fnins.2015.00220. eCollection 2015. Front Neurosci. 2015. PMID: 26136654 Free PMC article. Review.
-
Chronic administration of a norepinephrine antagonist prevents and partially reverses escalation of cocaine self-administration.Addict Biol. 2023 Sep;28(9):e13316. doi: 10.1111/adb.13316. Addict Biol. 2023. PMID: 37644893 Free PMC article.
-
Chronic pharmacological activation of SERCA with CDN1163 affects spatial cognitive flexibility but not attention and impulsivity in mice.Behav Pharmacol. 2023 Dec 1;34(8):477-487. doi: 10.1097/FBP.0000000000000756. Epub 2023 Oct 1. Behav Pharmacol. 2023. PMID: 37917567 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical